Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
E Pérez-Herrero, A Fernández-Medarde - European journal of …, 2015 - Elsevier
Cancer is the second worldwide cause of death, exceeded only by cardiovascular diseases.
It is characterized by uncontrolled cell proliferation and an absence of cell death that, except …
It is characterized by uncontrolled cell proliferation and an absence of cell death that, except …
Recent developments in natural biopolymer based drug delivery systems
Targeted delivery of drug molecules to diseased sites is a great challenge in pharmaceutical
and biomedical sciences. Fabrication of drug delivery systems (DDS) to target and/or …
and biomedical sciences. Fabrication of drug delivery systems (DDS) to target and/or …
IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy
IR-780 iodide is a near-infrared (NIR) fluorescence dye with higher and more stable
fluorescence intensity than clinically applied dye indocyanine green (ICG). Meanwhile, IR …
fluorescence intensity than clinically applied dye indocyanine green (ICG). Meanwhile, IR …
Polymeric nanomedicine for cancer therapy
Nanomedicine, an offshoot of nanotechnology, refers to highly specific, molecular-scale
medical intervention for treating disease or repairing damaged tissues. In recent years …
medical intervention for treating disease or repairing damaged tissues. In recent years …
Dendronized heparin− doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy
W She, N Li, K Luo, C Guo, G Wang, Y Geng, Z Gu - Biomaterials, 2013 - Elsevier
Heparin drug conjugates are currently investigated as excellent candidates for drug delivery
vehicles. In this study, we report the preparation and characterization of dendronized …
vehicles. In this study, we report the preparation and characterization of dendronized …
PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo
A major drawback of hyaluronic acid (HA)-based drug conjugates or nanoparticles for
cancer therapy is their preferential accumulation in the liver after systemic administration. In …
cancer therapy is their preferential accumulation in the liver after systemic administration. In …
Kinetic analysis of drug release from nanoparticles
M Barzegar-Jalali - Journal of Pharmacy & …, 2008 - journals.library.ualberta.ca
PURPOSE. Comparative drug release kinetics from nanoparticles was carried out using
conventional and our novel models with the aim of finding a general model applicable to …
conventional and our novel models with the aim of finding a general model applicable to …
Recent progress of nanocarrier-based therapy for solid malignancies
QY Wei, YM Xu, ATY Lau - Cancers, 2020 - mdpi.com
Simple Summary Although conventional anti-cancer drugs have been the footstone in the
fight against cancer, yet they are far from optimal due to issues related with indiscriminate …
fight against cancer, yet they are far from optimal due to issues related with indiscriminate …
Carbohydrate-based amphiphilic nano delivery systems for cancer therapy
K Liu, X Jiang, P Hunziker - Nanoscale, 2016 - pubs.rsc.org
Nanoparticles (NPs) are novel drug delivery systems that have been attracting more and
more attention in recent years, and have been used for the treatment of cancer, infection …
more attention in recent years, and have been used for the treatment of cancer, infection …
[HTML][HTML] Advances of cancer therapy by nanotechnology
X Wang, Y Wang, ZG Chen… - Cancer research and …, 2009 - synapse.koreamed.org
Recent developments in nanotechnology offer researchers opportunities to significantly
transform cancer therapeutics. This technology has enabled the manipulation of the …
transform cancer therapeutics. This technology has enabled the manipulation of the …